Condition: Parkinson Disease · Sponsor: Supernus Pharmaceuticals, Inc.
Real-World Participants Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: A Prospective, Phase 4, Multicenter, Observational Study in Parkinson's Disease
This description comes directly from the study's public registry record.
Mindy Grall, PhD ANP-BC · 18663980833 · mgrall@supernus.com
Supernus Supernus · 18663980833
Always discuss trial participation with your own doctor first.
| Parkinson's Disease and Movement Disorders Center - Orange County (South) | Aliso Viejo, California, United States | Recruiting |
| Parkinson's Disease and Movement Disorders Center - Orange County (North) | Irvine, California, United States | Recruiting |
| Parkinson's Research Centers of America - Palo Alto | Palo Alto, California, United States | Recruiting |
| Parkinson's Disease & Movement Disorders Center of Boca Raton | Boca Raton, Florida, United States | Recruiting |
| Parkinson's Disease and Movement Disorders Center - Long Island | Commack, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07219927